Study
EORTC-2148-MRD-HNCG-MG
Minimal Residual Disease Assessment
Trial Status
Recruiting
Dates
Date of activation: 23-May-2025
Data management at EORTC
Yes
Design
Cohort
Not randomized / N.A.
Not randomized / N.A.
Targeted Sample size
EORTC Groups: 250 - All Groups: 250
Study Staff
- Benjamin Besse (Study Coordinator), Gustave Roussy, VILLEJUIF CEDEX
- Rebecca Lee (Study Co-Coordinator), The Christie NHS Foundation Trust, Manchester
- Paul Lorigan (Study Co-Coordinator), The Christie NHS Foundation Trust, Manchester
- Jean-Pascal Machiels (Study Co-Coordinator), Cliniques Universitaires Saint-Luc, Brussels
- Marc Oliva Bernal (Y-ECI Coordinator), ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia), L' Hospitalet De Llobregat
- Alexandra Jouret (Project Manager), EORTC Headquarters, Brussels
- Bert Dhondt (Clinical Research Physician), EORTC Headquarters, Brussels
- Anne-Sophie Govaerts (Clinical Scientist), EORTC Headquarters, Brussels
- Jedelyn Cabrieto (Statistician), EORTC Headquarters, Brussels
- Michal Kicinski (Statistician), EORTC Headquarters, Brussels
- Fanny Grillet (TR Scientist), EORTC Headquarters, Brussels
- Cedric Mallien (TR Scientist), EORTC Headquarters, Brussels
- Benedicte Demeulder (Junior Clinical Operations Manager), EORTC Headquarters, Brussels
- Shani De Coster (Data Manager), EORTC Headquarters, Brussels
- Arnaud Poncin (Data Manager), EORTC Headquarters, Brussels
- Jelle Stans (Regulatory Affairs Manager), EORTC Headquarters, Brussels
- Anja Mestnik (Junior RAM), EORTC Headquarters, Brussels
- Lucy Sepulveda (Junior RAM), EORTC Headquarters, Brussels
- Dagmar Moravcova (Clinical Operations Assistant), EORTC Headquarters, Brussels
Type of cancer
- Melanoma
- Head and Neck
Participating groups
- EORTC Head and Neck Cancer Group
- EORTC Melanoma Group
Recruiting centers
- AZORG (previous Onze Lieve Vrouw ZK) (Aalst, Belgium)
- Athens University - Attikon University General Hospital (Athens, Greece)
- CHU Helora Pole Hospitalier Jolimont - Hopital Jolimont (Haine-Saint-Paul, Belgium)
- CHU Mont Godinne - UCL Namur (Yvoir, Belgium)
- CHU Site Sainte-Elisabeth-UCL Namur (Namur, Belgium)
- Centre Eugene Marquis (RENNES CEDEX, France)
- Centre Hospitalier D'Annecy Genevois (Pringy, France)
- Centre Hospitalier Departemental Vendee (LA ROCHE SUR YON CEDEX 9, France)
- Centre Leon Berard (Lyon, France)
- Centre de Radiotherapie Pierre Curie (Beuvry, France)
- Clatterbridge Cancer Center - Liverpool (Liverpool, United Kingdom)
- Cliniques Universitaires Saint-Luc (Brussels, Belgium)
- Gustave Roussy (VILLEJUIF CEDEX, France)
- Hospital Clinic de Barcelona (Barcelona, Spain)
- ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
- IRCCS - Fondazione Istituto Nazionale dei Tumori (Milano, Italy)
- Institut Bergonie (Bordeaux, France)
- Istituto Clinico Humanitas (Rozzano, Milano, Italy)
- NHS Lothian - Western General Hospital (Edinburgh, United Kingdom)
- Unidade Local de Saúde Gaia e Espinho (previously Cen.Hospitalar Vila Nova Gaia / Espinho) (Vila Nova De Gaia, Portugal)
- UniversitaetsSpital Zurich (Zurich, Switzerland)
- Universitaetsklinikum Greifswald der Ernst Morizt Arndt Univ. Greifswald AoR (Greifswald, Germany)
- Universitair Ziekenhuis Gent (Gent, Belgium)
- University Hospital Motol (Prague, Czech Republic)
Centers to be activated
- CHU Helora Pole Hospitalier Jolimont - Hopital Jolimont (Haine-Saint-Paul, Belgium)
- CHU de Lille (LILLE CEDEX, France)
- CHU de Nice - Hopital De L'Archet (NICE, France)
- Centre Hospitalier D'Annecy Genevois (Pringy, France)
- Centro Hospitalar Universitario Lisboa Norte - Hospital Sta. Maria (Lisboa, Portugal)
- Centro Hospitalar de Lisboa Ocidental- Sao Francisco Xavier Hospital (Lisboa, Portugal)
- Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (Berlin, Germany)
- East and North Hertfordshire NHS Trust – Mount Vernon Hospital (Northwood, United Kingdom)
- Greater Poland Cancer Centre (Poznan, Poland)
- Guy's and St Thomas' NHS - St Thomas Hospital (London, United Kingdom)
- Hospital Clinic de Barcelona (Barcelona, Spain)
- Hospital Universitario 12 De Octubre (Madrid, Spain)
- Hospital Universitario QuironSalud (Madrid, Spain)
- Hospital Universitario Virgen De La Victoria (Malaga, Spain)
- IRCCS - Fondazione Istituto Nazionale dei Tumori (Milano, Italy)
- IRCCS Ospedale San Martino (Genova, Italy)
- IRCCS-Regina Elena National Cancer Center (Roma, Italy)
- Institut Bergonie (Bordeaux, France)
- Instituto Portugues de Oncologia do Porto Francisco Gentil (Porto, Portugal)
- Klinikum Nuernberg- Standort Nord (Nuernberg, Germany)
- Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland)
- Medical University Of Gdansk (Gdansk, Poland)
- National Cancer Institute (Vilnius, Lithuania)
- North Estonia Medical Centre - Mustamae unit (Tallinn, Estonia)
- Santa Maria della Misericordia Hospital (Perugia, Italy)
- St George's University Hospital NHS Trust Foundation (London, United Kingdom)
- St. James'S Hospital (Dublin, Ireland)
- The Christie NHS Foundation Trust (Manchester, United Kingdom)
- Universitaetsklinikum Hamburg-Eppendorf KE - University Cancer Center (Hamburg, Germany)
- Universitair Ziekenhuis Brussel (Brussels, Belgium)
- University Clinical Center of Serbia - Clinic for ENT and MFH (Belgrade, Serbia)
- Vilnius University Hospital Santaras Clinics Branch-National Cancer Center (Vilnius, Lithuania)
- Warmia-Mazury Oncology center Olsztynie (Olsztyn, Poland)
Study
EORTC-2148-MRD-HNCG-MG
Minimal Residual Disease Assessment
Linked Studies
EORTC-1553-SPECTA
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access